Traded Nov 18, 2026 · largest single transaction ~$117K
Show all 2 transactions
Nov 18, 2026~$117K · 76K sh @ $1.53
DetailsOfficial recordNov 18, 2026~$36K · 24K sh @ $1.51
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CRVO · NASDAQ · Pharmaceutical Preparations
Cervomed (CRVO) · oqro.io/stocks/CRVO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$1.33−0.12 (−8.28%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day, not a live quote
20 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Traded Nov 18, 2026 · largest single transaction ~$117K
Nov 18, 2026~$117K · 76K sh @ $1.53
DetailsOfficial recordNov 18, 2026~$36K · 24K sh @ $1.51
DetailsOfficial recordInsider buying
Largest insider buy since 2013Traded Jun 11 · filed 4 days later
Since the trade −45.5% · S&P 500 −3.0% · to Nov 19
Bought 77% below the 52-week high, RSI 30, 60% under its 200-day average, 54 points behind the S&P 500 over 3 months
Traded Nov 17, 2025 · largest single transaction ~$91K
Nov 17, 2025~$91K · 11K sh @ $8.46
DetailsOfficial recordTraded Nov 17, 2025 · largest single transaction ~$91K
Nov 17, 2025~$91K · 11K sh @ $8.46
DetailsOfficial recordTraded Nov 17 – Nov 18, 2025 · largest single transaction ~$21K
Nov 18, 2025~$21K · 2,500 sh @ $8.32
DetailsOfficial recordTraded Nov 17 – Nov 18, 2025 · largest single transaction ~$30K
Nov 17, 2025~$30K · 3,500 sh @ $8.43
DetailsOfficial recordTraded Nov 13 – Nov 14, 2025 · largest single transaction ~$33K
Nov 13, 2025~$33K · 4,447 sh @ $7.51
DetailsOfficial recordInsider buying
4 insiders in a week, a first since 2013Traded Nov 14, 2025 · filed 3 days later
Since the trade −82.7% · S&P 500 +6.5% · to Nov 19
Bought 46% below the 52-week high, RSI 55, 2% above its 200-day average, 26 points behind the S&P 500 over 3 months
Traded Nov 13 – Nov 14, 2025 · largest single transaction ~$33K
Nov 13, 2025~$33K · 4,447 sh @ $7.51
DetailsOfficial recordInsider buying
3 insiders in a week, a first since 2013Traded Nov 12, 2025 · filed 1 day later
Since the trade −82.0% · S&P 500 +4.8% · to Nov 19
Bought 48% below the 52-week high, RSI 50, 1% under its 200-day average, 33 points behind the S&P 500 over 3 months
Insider buying
3 insiders in a week, a first since 2013Traded Nov 12, 2025 · filed 1 day later
Since the trade −82.0% · S&P 500 +4.8% · to Nov 19
Bought 48% below the 52-week high, RSI 50, 1% under its 200-day average, 33 points behind the S&P 500 over 3 months
Insider buying
3 insiders in a week, a first since 2013Traded Nov 12, 2025 · filed 1 day later
Since the trade −82.0% · S&P 500 +4.8% · to Nov 19
Bought 48% below the 52-week high, RSI 50, 1% under its 200-day average, 33 points behind the S&P 500 over 3 months
Insider buying
Traded May 14, 2025 · filed the same day
Since the trade −84.0% · S&P 500 +21.8% · to Nov 19
The CFO of Cervomed paid $36K out of pocket for Cervomed shares. Shares held went up 334% with this purchase.
Nov 17, 2025~$91K · 11K sh @ $8.46
DetailsOfficial recordNov 17, 2025~$91K · 11K sh @ $8.46
DetailsOfficial recordNov 17, 2025~$8.4K · 1,000 sh @ $8.45
DetailsOfficial recordNov 18, 2025~$12K · 1,500 sh @ $7.95
DetailsOfficial recordNov 14, 2025~$13K · 1,707 sh @ $7.57
DetailsOfficial recordNov 14, 2025~$13K · 1,693 sh @ $7.55
DetailsOfficial recordNov 14, 2025~$13K · 1,693 sh @ $7.55
DetailsOfficial recordNov 14, 2025~$13K · 1,707 sh @ $7.57
DetailsOfficial record1 open-market purchase and 0 open-market sales by insiders of CRVO between Feb 15, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 9, 2026. The data provider lists the next release for Mar 11, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 9, 2026 | None | None | None |
| Aug 10, 2026 | None | None | None |
| May 18, 2026 | None | None | 1 purchase |
| Mar 17, 2026 | None | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies